Topic
Medical field using vaccines, checkpoint inhibitors, cell therapies, and other immune-boosting treatments to help the body recognize and destroy cancer cells.
Merck and Moderna's mRNA vaccine intismeran autogene slowed the return and spread of melanoma when added to an existing treatment in a late-stage trial. One trial cannot say which other cancers the same approach can treat.
Reality
Intismeran autogene met both primary endpoints in a 1,137-patient melanoma trial. Every dose is built from one tumour's sequence, which turns approval into a question about process, not product.
Perspective Coverage
3 publishersReality
Memorial Sloan Kettering researchers used nanoparticles to kill a scar-driving macrophage subset, restoring immunotherapy in mice with liver and lung cancer. The Science paper points to the tumor's fibrotic barrier as a route past immunotherapy resistance.
Reality
The WashU group reports in Nature that the structures activate in mice before distant lymph nodes get the signal, and that a gel of three immune proteins placed under the scalp boosted the antitumor response.
Reality
In Science, a Salk Institute team reports that melanoma cells held in type II interferon spill double-stranded mitochondrial RNA, setting off a type I response that raises COX2 and PGE2, and those cells grew tumors faster in mice.
Reality
Every treated animal cleared its primary tumor in a drug-resistant mouse model. Two of the platform's three arms only fire when a laser reaches the tissue.
Reality
A lipid nanoparticle that carries antigen mRNA, STING mRNA and a delayed-release activator addresses the reason cGAS-STING adjuvants keep failing: the agonist shuts down antigen translation.
Reality